Terms: = Leukemia AND HIP1, ILWEQ, 3092, ENSG00000127946
19 results:
1. [Impact of duration of antibiotic therapy on the prognosis of patients with acute myeloid leukemia who had Gram-negative bloodstream infection in consolidation chemotherapy].
Gu RX; Wei H; Wang Y; Liu BC; Zhou CL; Lin D; Liu KQ; Wei SN; Gong BF; Zhang GJ; Liu YT; Zhao XL; Gong XY; Li Y; Qiu SW; Mi YC; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2018 Jun; 39(6):471-475. PubMed ID: 30032562
[No Abstract] [Full Text] [Related]
2. Prognostic significance of huntingtin interacting protein 1 expression on patients with acute myeloid leukemia.
Wang J; Yu M; Guo Q; Ma Q; Hu C; Ma Z; Yin X; Li X; Wang Y; Pan H; Wang D; Huang J; Meng H; Tong H; Qian W; Jin J
Sci Rep; 2017 Apr; 7():45960. PubMed ID: 28452374
[TBL] [Abstract] [Full Text] [Related]
3. Toward a therapeutic reduction of imatinib refractory myeloproliferative neoplasm-initiating cells.
Philips ST; Hildenbrand ZL; Oravecz-Wilson KI; Foley SB; Mgbemena VE; Ross TS
Oncogene; 2014 Nov; 33(46):5379-90. PubMed ID: 24240679
[TBL] [Abstract] [Full Text] [Related]
4. Persistence of leukemia-initiating cells in a conditional knockin model of an imatinib-responsive myeloproliferative disorder.
Oravecz-Wilson KI; Philips ST; Yilmaz OH; Ames HM; Li L; Crawford BD; Gauvin AM; Lucas PC; Sitwala K; Downing JR; Morrison SJ; Ross TS
Cancer Cell; 2009 Aug; 16(2):137-48. PubMed ID: 19647224
[TBL] [Abstract] [Full Text] [Related]
5. [Burden of major cancers on years of life lost with premature death in crocidolite-contaminated area in Dayao].
Zou H; Luo SQ; Yang CY; Zhang MB
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2007 Jun; 25(6):326-30. PubMed ID: 17723186
[TBL] [Abstract] [Full Text] [Related]
6. Sensitivity to imatinib but low frequency of the TEL/PDGFRbeta fusion protein in chronic myelomonocytic leukemia.
Gunby RH; Cazzaniga G; Tassi E; Le Coutre P; Pogliani E; Specchia G; Biondi A; Gambacorti-Passerini C
Haematologica; 2003 Apr; 88(4):408-15. PubMed ID: 12681968
[TBL] [Abstract] [Full Text] [Related]
7. Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survival.
Rao DS; Hyun TS; Kumar PD; Mizukami IF; Rubin MA; Lucas PC; Sanda MG; Ross TS
J Clin Invest; 2002 Aug; 110(3):351-60. PubMed ID: 12163454
[TBL] [Abstract] [Full Text] [Related]
8. Myeloproliferative disorders with translocations of chromosome 5q31-35: role of the platelet-derived growth factor receptor Beta.
Steer EJ; Cross NC
Acta Haematol; 2002; 107(2):113-22. PubMed ID: 11919393
[TBL] [Abstract] [Full Text] [Related]
9. Huntingtin interacting protein 1 Is a clathrin coat binding protein required for differentiation of late spermatogenic progenitors.
Rao DS; Chang JC; Kumar PD; Mizukami I; Smithson GM; Bradley SV; Parlow AF; Ross TS
Mol Cell Biol; 2001 Nov; 21(22):7796-806. PubMed ID: 11604514
[TBL] [Abstract] [Full Text] [Related]
10. Rabaptin-5 is a novel fusion partner to platelet-derived growth factor beta receptor in chronic myelomonocytic leukemia.
Magnusson MK; Meade KE; Brown KE; Arthur DC; Krueger LA; Barrett AJ; Dunbar CE
Blood; 2001 Oct; 98(8):2518-25. PubMed ID: 11588050
[TBL] [Abstract] [Full Text] [Related]
11. Regulation of the Src homology 2-containing inositol 5-phosphatase Ship1 in hip1/PDGFbeta R-transformed cells.
Saint-Dic D; Chang SC; Taylor GS; Provot MM; Ross TS
J Biol Chem; 2001 Jun; 276(24):21192-8. PubMed ID: 11287412
[TBL] [Abstract] [Full Text] [Related]
12. Fusion of H4/D10S170 to the platelet-derived growth factor receptor beta in BCR-ABL-negative myeloproliferative disorders with a t(5;10)(q33;q21).
Kulkarni S; Heath C; Parker S; Chase A; Iqbal S; Pocock CF; Kaeda J; Cwynarski K; Goldman JM; Cross NC
Cancer Res; 2000 Jul; 60(13):3592-8. PubMed ID: 10910073
[TBL] [Abstract] [Full Text] [Related]
13. Synthesis and cytostatic properties of structure-simplified analogs of dolastatin 15.
Hu MK; Huang WS
J Pept Res; 1999 Dec; 54(6):460-7. PubMed ID: 10604591
[TBL] [Abstract] [Full Text] [Related]
14. Transforming properties of the Huntingtin interacting protein 1/ platelet-derived growth factor beta receptor fusion protein.
Ross TS; Gilliland DG
J Biol Chem; 1999 Aug; 274(32):22328-36. PubMed ID: 10428802
[TBL] [Abstract] [Full Text] [Related]
15. Characterization of the human transcobalamin II promoter. A proximal GC/GT box is a dominant negative element.
Li N; Seetharam S; Seetharam B
J Biol Chem; 1998 Jun; 273(26):16104-11. PubMed ID: 9632663
[TBL] [Abstract] [Full Text] [Related]
16. Fusion of Huntingtin interacting protein 1 to platelet-derived growth factor beta receptor (PDGFbetaR) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2).
Ross TS; Bernard OA; Berger R; Gilliland DG
Blood; 1998 Jun; 91(12):4419-26. PubMed ID: 9616134
[TBL] [Abstract] [Full Text] [Related]
17. Indications and donor source of hematopoietic stem cell transplants in Europe 1993: report from the European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Hermans J
Clin Transplant; 1995 Oct; 9(5):355-63. PubMed ID: 8541627
[TBL] [Abstract] [Full Text] [Related]
18. Hematologic, clinical, and cytogenetic analysis in 109 patients with primary myelodysplastic syndrome. Prognostic significance of morphology and chromosome findings.
Parlier V; van Melle G; Beris P; Schmidt PM; Tobler A; Haller E; Bellomo MJ
Cancer Genet Cytogenet; 1994 Dec; 78(2):219-31. PubMed ID: 7828157
[TBL] [Abstract] [Full Text] [Related]
19. The selective use of AMSA following high-dose cytarabine in patients with acute myeloid leukaemia in relapse: a leukemia Intergroup study.
Larson RA; Day RS; Azarnia N; Bennett JM; Browman G; Goldberg J; Gottlieb A; Grunwald H; Miller K; Raza A
Br J Haematol; 1992 Oct; 82(2):337-46. PubMed ID: 1419816
[TBL] [Abstract] [Full Text] [Related]
